Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-11-13
1989-09-19
Sneed, H. M. S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514180, A61K 3156
Patent
active
048681695
ABSTRACT:
A steroid cream formulation which has enhanced physical and chemical stability is formed of (11.beta.,17.alpha.)-17-(ethylthio)-9.alpha.-fluoro-11.beta.-hydroxy-17-(m ethylthio)androsta-1,4-dien-3-one (tipredane), and a vehicle containing as major ingredients glyceryl monostearate having an acid value of greater than 4, propylene glycol and water together with a sodium citrate or potassium citrate buffer, a non-acidic long chain fatty acid wax to impart proper consistency, and sodium metabisulfite as an antioxidant, together with emulsifiers, skin conditioners, emollients, lubricants and other conventional cream formulation ingredients.
REFERENCES:
patent: 3178345 (1965-04-01), Schlagel
patent: 4361559 (1982-11-01), Varma
patent: 4542129 (1985-09-01), Orentreich
O'Laughlin Richard L.
Panaggio Andrea
Varia Sailesh A.
E. R. Squibb & Sons Inc.
Rodney Burton
Saba J.
Sneed H. M. S.
LandOfFree
Steroid cream formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroid cream formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid cream formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-368793